Novel surface polypeptides of Campylobacter jejuni as traveller's diarrhoea vaccine candidates discovered by proteomics

Vaccine

Volumn 24, Issue 40-41, 2006, Pages 6446-6455

  Prokhorova, T A ^a   Nielsen, P N ^a   Petersen, J ^a   Kofoed, T ^a   Crawford, J S ^a   Morsczeck, C ^a   Boysen, A ^a   Schrotz King, P ^a  

^a ACE BioSciences AS   (Denmark)

Author keywords

Campylobacter jejuni; Protein vaccine; Proteomics; Traveller's diarrhoea

Indexed keywords

BACTERIAL VACCINE; POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; ESCHERICHIA COLI; FOOD POISONING; FRACTIONATION; GRAM NEGATIVE INFECTION; IMMUNIZATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TRAVELLER DIARRHEA; UNINDEXED SEQUENCE;

ANIMALS; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BACTERIAL VACCINES; CAMPYLOBACTER JEJUNI; DIARRHEA; MICE; PEPTIDES; PROTEOMICS; TRAVEL;

EID: 33748307473     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.085     Document Type: Article

References (24)

1. Altekruse S.F., Stern N.J., Fields P.I., and Swerdlow D.L. Campylobacter jejuni-An emerging foodborne pathogen. Emerg Infect Dis 5 1 (1999) 28-35
2. WHO. Fact sheet No. 255 November; 2000 http://www.who.int/mediacentre/factsheets/fs255/en/.
3. Scott D.A. Vaccines against Campylobacter jejuni. J Infect Dis 176 Suppl 2 (1997) S183-S188
4. Scott D.A., and Tribble D.R. Protection against Campylobacter infection and vaccine development. In: Nachamkin I., and Blaser M.J. (Eds). Campylobacter (2000), American Society of Microbiology, Washington, DC 303-319
5. Black R.E., Levine M.M., Ferreccio C., Clements M.L., Lanata C., and Rooney J. Germanier efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee Vaccine 8 1 (1990) 81-84
6. Kaper J.B., Lockman H., Baldini M.M., and Levine M.M. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 308 5960 (1984) 655-658
7. Yao R., Burr D.H., Doig P., Trust T.J., Niu H., and Guerry P. Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol 14 5 (1994) 883-893
8. Ziprin R.L., Hume M.E., Young C.R., and Harvey R.B. Inoculation of chicks with viable non-colonizing strains of Campylobacter jejuni: evaluation of protection against a colonizing strain. Curr Microbiol 44 3 (2002) 221-223
9. Hughes R.A., and Cornblath D.R. Guillain-Barre syndrome. Lancet 366 9497 (2005) 1653-1666
10. Baqar S., Bourgeois A.L., Schultheiss P.J., Walker R.I., Rollins D.M., Haberberger R.L., et al. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13 1 (1995) 22-28
11. Burr D.H., Rollins D., Lee L.H., Pattarini D.L., Walz S.S., Tian J.H., et al. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine. Vaccine 23 34 (2005) 4315-4321
12. Martin P.M., Mathiot J., Ipero J., Kirimat M., Georges A.J., and Georges-Courbot M.C. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infect Immun 57 8 (1989) 2542-2546
13. Wenman W.M., Chai J., Louie T.J., Goudreau C., Lior H., Newell D.G., et al. Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol 21 1 (1985) 108-112
14. Sizemore DR, Warner B, Lawrence J, Jones A, Killeen KP. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens. Vaccine; 2005.
15. Parkhill J., Wren B.W., Mungall K., Ketley J.M., Churcher C., Basham D., et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403 6770 (2000) 665-668
16. Lee L.H., Burg III E., Baqar S., Bourgeois A.L., Burr D.H., Ewing C.P., et al. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect Immun 67 11 (1999) 5799-5805
17. Endtz H.P., Ruijs G.J., Zwinderman A.H., van der Reijden T., Biever M., and Mouton R.P. Comparison of six media, including a semisolid agar, for the isolation of various Campylobacter species from stool specimens. J Clin Microbiol 29 5 (1991) 1007-1010
18. Pei Z., and Blaser M.J. PEB1, the major cell-binding factor of Campylobacter jejuni, is a homolog of the binding component in Gram-negative nutrient transport systems. J Biol Chem 268 25 (1993) 18717-18725
19. Doig P., Yao R., Burr D.H., Guerry P., and Trust T.J. An environmentally regulated pilus-like appendage involved in Campylobacter pathogenesis. Mol Microbiol 20 4 (1996) 885-894
20. Ling E., Feldman G., Portnoi M., Dagan R., Overweg K., Mulholland F., et al. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 138 2 (2004) 290-298
21. Lior H., Woodward D.L., Edgar J.A., Laroche L.J., and Gill P. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol 15 (1982) 761-768
22. Walker R.I. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23 26 (2005) 3369-3385
23. Guthrie T., Hobbs C.G., Davenport V., Horton R.E., Heyderman R.S., and Williams N.A. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 190 11 (2004) 1927-1935
24. Young V.B., Schauer D.B., and Fox J.G. Animal models of Campylobacter infection. In: Nachamkin I., and Blaser M.J. (Eds). Campylobacter (2000), American Society of Microbiology, Washington, DC 287-301